Retour aux projets

25866.2 PFLS-LS

Development of human therapeutic antibodies against peanut allergy

Résumé

Development of human therapeutic antibodies against peanut allergy

Textes supplémentaires

Abstract

The project aims at developing human antibodies for the prevention of severe allergic reactions to peanuts. By combining ImmunoQure Research's expertise in human antibody discovery, validation, and development with expertise in basic and clinical allergology research at the University of Zurich, we will develop an urgently needed therapy for peanut allergic patients.

Participants

Alcide Barberis

Wirtschaftspartner

barberis@mabylon.com

Mabylon AG Alcide Barberis Wagistrasse 14 8952 Schlieren ZH CH

Pal Johansen

Kontaktperson

pal.johansen@usz.ch

USZ Universitätsspital Zürich Dermatologie Pal Johansen Gloriastrasse 31 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2018-08-08
Date de fin
2022-07-08
Coûts totaux approuvés
CHF 933830.71
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%